STAAR Surgical Company (STAA)
Makes implantable lenses to correct vision problems like nearsightedness and astigmatism
$22.68-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+27.7%
The outlook
STAAR Surgical trades near $22.68, well below both its 50- and 200-day moving averages, placing it in the lower third of its 52-week range. Analysts lean toward a "Buy" rating, with an average price target about 27% above the current price. The overall sentiment is neutral, reflecting mixed signals between bullish analyst views and the stock's weak recent technical position.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 9 analysts
Price trendBelow its 50- & 200-day averages
52-week range35% of the way from its 52-week low to high
Price targetAvg target +27% vs current price
Analyst price target
~12-month · 9 analysts$28.89average target+27.4% vs now
Now $22.68
Low $20.00High $40.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.13B
52-wk high
$35.87
52-wk low
$15.59
50-day avg
$28.80
200-day avg
$24.39
Trailing P/E
—